Picard Medical (PMI) Convertible Debt (2024 - 2025)

Picard Medical (PMI) reported Convertible Debt of $14.8 million for Q2 2025, down 0.51% quarter-over-quarter from $14.8 million in Q4 2024.

Picard Medical (PMI) Convertible Debt (2024 - 2025) Analysis & Trends

Picard Medical has reported Convertible Debt for 2 years, with the latest figure at $14.8 million in Q2 2025.

  • For the quarter ending Q2 2025, Convertible Debt changed N/A year-over-year to $14.8 million; the trailing twelve-month figure through Jun 2025 stood at $14.8 million (changed N/A YoY), and the FY2024 full-year result was $14.8 million, changed N/A from the prior year.
  • Convertible Debt for Q2 2025 stood at $14.8 million, down from $14.8 million in the prior quarter.
  • The five-year high for Convertible Debt was $14.8 million in Q4 2024, with the low at $14.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Picard Medical 13.47 Mn 13.47 Mn 275,000.00

Historic Data

Download Data
DateValue
Jun 30, 2025 14.75 Mn
Dec 31, 2024 14.83 Mn